Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
  • Looking for advise as to how to deploy cash
    Dear Dex: If you still have a Vanguard account, get back in and stay the course. Being out of the market the last three years has cost you a lot of money !
    Regards,
    Ted
    Vanguard Fund Recommendations:
    VGHCX
    VASVX
    VHCOX
    VWELX
  • Actively Managed Mutual Funds Fall Short Again-- And Investors Notice
    Reply to @BobC:
    Hi BobC,
    Nobel Laureate Bill Sharpe would be proud of your understanding of the risk/reward tradeoff. His Sharpe Ratio was one of the earliest attempts to capture and characterize both critical aspects of the investment puzzle. Later researchers, standing on his shoulders, refined his formulations.
    Indeed, if your active fund manager accepts more risk in a bull market scenario, an investor would expect outsized, above average returns. Of course, the reverse would be true under bear market conditions; under those circumstances, an investor would anticipated above average downward penalties. A symmetry should exist. ( A really skilled active fund manager should operate to dampen those downward penalties. )
    That is one of the essential findings that evolved from Sharpe’s early 1960s Capital Asset Pricing Model (CAPM). From that model, much to Sharpe’s annoyance, research peers and financial journalists coined the sensitivity of an investment to the overall market movement its Beta attribute. Since those early pioneering days, other factors have been identified that contribute to the investments pricing mechanism (size, value, momentum). Also various offshoots of Prospect Theory suggest that Beta is likely not symmetrical depending on either an upward or downward trending equity marketplace (like the Sortino Ratio).
    I suspect, based on the CAPM concept, Professor Snowball was astonished and disappointed by the general results he reported in his chosen illustrative example between the S&P 500 Index returns and those registered by the Large Cap Blend active fund category. The Large Cap Blend Capture Ratios fell short of their benchmark targets in both directions.
    Given the long-term consistency of both the SPIVA report findings and its sister Persistency Scorecard semi-annual report conclusions, the Capture Ratios did not shock me. It is yet another illustration of the daunting hurdles that active fund management continues to trip-over.
    Bill Sharpe explained this compactly and convincingly in his 1960s analysis using simple arithmetic and a market-wide overall returns balance equation. Among the active manager cohort, there must be a loser for every winner. Before costs, it is a zero sum game. Given research and trading costs, and other management fees, it is a negative sum game. That’s equivalent to a racetrack that typically only returns about 85 % of the total waged in any given race to its betting public. The 15 % withheld covers operating costs, profits, and State tax largess.
    So, on average, active managers do not reward their clients with above average returns. That’s impossible. On the downside, active managers again failed to protect their customers portfolios. The evidence has been accumulating for decades and has reached overwhelming proportions. Skilled managers do exist, but they are rare.
    Even those who sport an excess returns average record find persistency a daunting challenge. Costs matter greatly. The near empty winners circle is populated by active managers who aggressively control costs and have low portfolio turnover ratios.
    These few managers do thrive. I’m sure you hunt them out for your clients. The Vanguard Health Care fund (VGHCX) is a prime example. Over the last decade, it has outperformed its benchmark in 9 out of 10 years, including two annual downward market thrusts. Its low cost structure and low portfolio turnover rates made it a likely candidate to do so.
    Even institutions are finally realizing the extreme difficulties of identifying superior active fund managers. The huge California retirement agency CALpers will likely be increasing its passively managed equity portfolios from a 30 % overall level to a 60 % commitment in the near future. The CALpers team carefully screened active managers, but these chosen Ones failed the acid market exposure over fair test periods.
    The Litman/Gregory mutual fund organization, which emphasized portfolios constructed by a diligent and detailed multi-manager selection process, has not generated superior rewards. Manager changes have been made far more frequently than planned. Litman/Gregory is discovering that management selection is a tough nut.
    Allow me to take exception to your assertion that folks would be satisfied with an 85 % return when accompanied by an 80 % risk statistic (undefined at this moment). I’m sure some folks would find that an acceptable tradeoff. I’m equally sure many other folks would not be so happy, especially those with a long-term investment horizon.
    So I would never be sanguine over quoting any single set of target numbers for investors as a whole. It depends on a multi-dimensional set of requirements, preferences, wealth status, knowledge base, age, goals, and risk adversity attributes. I’m sure I am preaching to the choir now.
    Choosing successful active mutual fund managers is a hard road. I know you try; most everyone at MFO tries; so do I. I have prospered a little but have been saddled with some poor choices as well as some successful ones. I am not sure it is worth the effort and the heartache. I hope and wish you more success than I enjoyed in this demanding and vexing arena.
    Best Wishes.
  • Healthcare Fund: Pick one
    Will patiently wait years for VGHCX to tank and then buy. Just like I patiently held for years and then sold for very nice profit this year (and early I might admit). When vs Why rules baby!!!
    Frankly, it was a sector fund and I wanted out. So I'm kidding. I will not be buying it back again.
  • Healthcare Fund: Pick one

    Ted: You got me there; but in any given year, I will gladly take the returns of any of the 3 funds: PRHSX, FSPHX, VGHCX. They are all good - like I wrote, I had my eyes on those juicy dividends, but I am sure the returns in marketwatch includes re-invested dividends. Yes, PRHSX is also a worthy choice.
  • Healthcare Fund: Pick one
    Reply to @bumine: 50/50 split between FSPHX & VGHCX cost you 1.14%, PRHSX cost .79%, and has better short and long-term returns.
    Regards,
    Ted
    http://www.marketwatch.com/tools/mutual-fund/compare?Tickers=FSPHX+VGHCX+PRHSX&Compare=Returns
  • Healthcare Fund: Pick one
    POAGX is an excellent fund with Healthcare (33.7%) and Technology (29.6%) dominating the top sectors. But check out the dividends on those dedicated Health sector funds :-); particularly, FSPHX and VGHCX!!!
    Faced with a similar decision a year ago, I did 50/50 on FSPHX and VGHCX (the dividends being a factor in the decision to pick these 2 over PRHSX).
    If you insist on one, I will lean towards FSPHX: it has the lowest asset base, expense is about the same as PRHSX (0.78 vs 0.79); both PRHSX and FSPHX have higher returns than VGHSX with the lower expense of 0.35.
    Have fun and let us know your final decision.
  • Healthcare Fund: Pick one
    Hi folks,
    I'm looking to add a healthcare fund/etf to my solo 401k. Having a hard time picking between T Rowe Price Health Sciences (PRHSX), Fidelity Select Health Care (FSPHX), Vanguard Health Care (VGHCX) and Vanguard Health Care ETF (VHT). It's more-or-less a coin flip, though, I'm leaning slightly toward PRHSX for no reason, other than I've done well with the other TRP funds I own, though the recent manager change is a bit of a caution note. I'd appreciate any thoughts, insight, or input that might help break the tie.
    Thanks.
  • Investing Around ObamaCare: XLV
    I am about ready to poke my eyes out with a pencil the next time I read the false narrative of the "government take-over of healthcare".
    Aside from that....I am long healthcare in the form of large positions in POAGX, VGHCX and VHCOX...along with some individual stock holdings. I also work in the health science industry, working with several big pharma in their efforts to move compounds through the clinical trial process.
    Here is a general question which illustrates my long-term affinity for the health science industry from an investment perspective. If more people will be entering the world of healthcare coverage in the US, why would the suppliers for products required by this new market population experience anything other than an increase in demand for their products?
  • What are your Un"herd" like funds...Spinning off Mike M post
    Reply to @hank:
    Thanks for your response. I agree with you on both of your unloved sectors...NR, Miners, Metals...and International Bonds. I own VGPMX long term in the Metals & Mining space and I added to it in June with some profits from VGHCX. My two IB positions are PYEMX and TGBAX. I am trying meet a $50K initial minimum so I can replace TGBAX with TTRZX. Good IB fund managers will find a way through these bond issues and I believe these managers are worth finding and staying invested in at some percentage level.
    Another sector with the hiccups recently in my portfolio has been Real Estate related investments.
    Typically when sectors (sector funds) under performs they move to the front of the minds of most investors. The herd often will sell...some hold on a little longer...a few buy more. If these funds are long term holds in my portfolio, such as real estate, NR and IB are for me (in small amounts) I like to think I am discipline enough to reallocate some of my portfolio into these holdings. My brain counters with thoughts of picking bottoms or catching a falling knife. A portfolio game plan of disciplined emotionless mechanical rebalancing is a challenging process for us humans.
    I have often wondered ..."would a single balanced funds do a better job of balancing a collection of allocations (investments) than a individual investor balancing a collection of funds for their collective portfolio?"
  • "Defensive" funds?
    Over the years, I have concluded that my most defensive yet profitable pure equity fund is VGHCX. Big, lumbering pharma is a keeper. It's one of the places people go when they're nervous.
  • Scott - Where's your thread "Where are you investing now"?
    I try to take quarterly profits when any fund I own has gained 10%...more often than not I wait a lot longer then 3 months, but by doing a review quarterly I usually avoid early redemption fees and I find that there is at least a few holdings that have performed well enough to sell some shares.
    If the holding is an opportunistic position and it shows signs of upward momentum I usually will only take the 10% gain and monitor its momentum more closely. I like to use a pairing system with my mutual funds.
    Recently, I have been pairing BUFBX and BUFOX. In this case I use BUFBX as my long term hold and BUFOX as my opportunistic position. Here are the two funds over the last quarter:
    image
    In this case I will take my 20% gain from BUFOX (referenced against BUFBX) and reallocate it to BUFBX. I will check momentum of BUFOX against BUFBX on a 1 month basis going forward. Here's the most recent 1 month chart:
    image
    As you can see, BUFOX continues to have positive momentum compared to BUFBX. If things reverse I will often get out of the agressive position and continue monitoring it for reentry or look for other trending funds.
    I have tried this also with:
    Mathews Funds: MAPIX and MSMLX
    TR Price: PRWCX and many other T R Price Funds (PRMTX, PRHSX, PRIDX, PRNHX, etc)
    Vanguard: VWELX and other Vanguard Funds (VHCOX, VGHCX, VGENX,VGSIX,etc.)
    Pimco: PONDX and other Pimco Funds (PCKDX, PETDX, PCRDX, etc.)
    Oakmark: OAKBX and other Oakmark Funds ( OAKIX, OAKWX, etc.)
    I try to do these investment pairing within the same fund family because my brokerage allow me to exchange funds on the same day. This provides me with the ability to sell profits from my opportunistic funds and buy shares of my "long term hold" fund on the same day. Choosing funds that are NTF also eliminates transaction fees.
    Would like to hear from others on their reallocation strategies.
  • I am considering adding a health or health science fund in my IRA
    Here are risk/performance numbers of some of those mentioned above, along with some of better performers in the Health category (although ISTIX / WSTCX actually resides in the Tech category):
    image
    I know VGHCX has had a manager change, but hard not to be attracted to this fund.
  • Vanguard fund suggestions
    Hi mrc,
    Here are some more actively managed Vanguard funds for your consideration: VSTCX, VSEQX, VEXPX/VEXRX, VDEQX, VWIAX/VWINX, VGELX/VGENX, and VGHAX/VGHCX.
    Kevin
  • What are your favorite Vanguard funds?
    VWINX
    VWELX
    VGENX
    VGHCX
    VGPMX
    VWINX, VWELX, and VGHCX probably three of the best funds ever.
    Sometimes, because your plan owns shares, you may even be able to buy otherwise closed funds, like VWELX.
    Also, opt for admiral share class, as appropriate.
  • VGCHX (Vanguard Health) - still worthy of investment?
    Health Care and more specifically Biotech have had a nice run...even with that in mind, dca into VGHCX would make sense to me. We are in a transitory period for Healthcare (ObamaCare). Companies are jockey for position and in the end this sector will see upside from this political intiative. Beyond politics, Healthcare is the place to be as countries like the US, Japan, and China age. I like the dividends VGHCX throws off (1.63%)...I like the growth potential (5 yr avg 11.31%).
    Fifteen years with the same girl (VGHCX) should count for something, right? She's a keeper in my book.
  • my plus side funds this week
    Funds with positive MONTHLY return on my list. In order of % return. From 3.17 to 0.03
    SPLV
    MLPI
    VGHCX
    AQMIX
    POGRX
    MAPIX
    MACSX
    PGDIX
    AIMOX
    AMOMX
    VEIPX
    LSBRX
    FNMIX
    TIBIX
    TGBAX
    PGAIX
    FSMEX
    VWINX
    FSICX
    VBMFX
    PIMIX
    PTTRX
    VWELX
    PAUIX
    VWEHX
    PHIYX
    MWTRX
    FMIHX
    HABDX
    OSTIX
    EXDAX
    TGMNX
    VFINX
    VIPSX
    IVIQX
    VTINX
    PFIUX
    FEHIX
    PRWCX
    VIMSX
    SNXFX
    AQGNX
    LEXCX
    TGEIX
    VGSTX
    VTSAX
    AQRIX
    VFSTX
    JASBX
    MAPOX
    BERIX
    FPACX
  • Your longest held positions
    Hi folks,
    I wanted to recap this thread the best I can. First of all, thanks to all for the contributions. For some odd reason, I thought the number of holdings extending beyond 10 years would be slight....what in God's name was I thinking?
    Listed below are those held more than 10 years per responses:
    ACRNX Columbia Acorn
    ARTJX Artisan International Small Cap
    ARTKX Artisan International Value
    ARTMX Artisan Mid Cap
    ARTVX Artisan Small Cap Value
    BSCFX Baron Small Cap
    DODBX Dodge & Cox Balanced
    EUROX U.S. Global Investors Eastern European
    FCNTX Fidelity Contra Fund
    HABDX Harbor Bond
    IVAEX Ivy Asset Strategy
    LSBDX Loomis Sayles Bond
    MACSX Matthews Asian Growth and Income
    MAPTX Matthews Pacific Tiger
    MEURX Mutual European Fd (Series of Franklin Mutual Ser Fd Inc.)
    MSILX Litman Gregory Masters International
    OAKBX Oakmark Equity and Income
    OARIX Oakmark International
    ODVYX Oppenheimer Developing Markets
    OSTFX Osterweis Fund
    OSTIX Osterweis Strategic Income
    PCVAX AllianzGI NFJ Small-Cap Value
    PRBLX Parnassus Income Trust- Equity Income
    PRPFX Permanent Pt
    PRWCX T. Rowe Price Capital Appreciation
    RPIBX T. Rowe Price International Bond
    RPMGX T. Rowe Price Mid-Cap Growth
    SINAX ClearBridge Large Cap Value
    SEQUX Sequoia
    SGOVX First Eagle Overseas
    TBGVX Tweedy Browne Global Value
    TGBAX Templeton Global Bond
    TIBIX Thornburg Investment Income Builder
    TWVLX American Century Value Investor
    VGHCX Vanguard Specialized Portfolios Health Care
    VHCOX Vanguard Capital Opportunity
    VISVX Vanguard Index Trust Small-Cap Value
    VPMCX Vanguard Primecap
    VWELX Vanguard Wellington
    What great fund pickers we are!!!
    Frankly, I think this says a great deal about the folks who visit this site, and particularly the individual (David) who operates the site which draws us in like moths to a flame...ok, bad analogy.
    Many of the funds listed were not popular, trendy or acclaimed 10 years ago...but they are now. The key is finding these types of funds early...and that is what I hope to get from this site, and fellow posters.
    On a personal note, it was interesting to see that while I only have owned 2 funds for over 10 years, I own 11 of the funds on this list currently.
    thanks,
    Press
  • The hotter than hot sector
    Speaking of health care as an investment in general, Robert Shiller is the guest on the current WealthTrack show, where he says that there are four sector PE10's still below the median of the past 20 years: finance, energy, health care, and industrials -- so on that basis, the long-term valuation of funds like VGHCX even now is pretty decent for prospective buyers.
  • Your longest held positions
    VWELX - Since 80s. Inertia. Soon I'll be Admiralized.
    VGHCX - Since 80s. Bought at $30; last close a whisker short of $160. Yippee!
    ACRNX - Since early 90s. Inertia.
    ARTMX - When fund managers left Strong and started Artisan, I went with them. Like David, I bought, then sold, Artisan Small and International, putting the proceeds (unlike David) into ARTMX and Mid Value.
    Value bent, pretty obviously.
    TBGVX (Burton Malkiel's influence)
    VISVX